CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206. A total of 26 filers reported holding CATABASIS PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,634,000 | -50.9% | 1,248,317 | -32.7% | 0.03% | -56.5% |
| Q1 2021 | $5,363,000 | +4912.1% | 1,855,926 | +3611.9% | 0.07% | +3350.0% |
| Q4 2020 | $107,000 | -65.5% | 50,000 | 0.0% | 0.00% | -60.0% |
| Q3 2020 | $310,000 | -95.7% | 50,000 | -95.6% | 0.01% | -95.5% |
| Q2 2020 | $7,234,000 | +54.1% | 1,125,000 | -0.5% | 0.11% | +18.3% |
| Q1 2020 | $4,694,000 | -36.5% | 1,131,039 | -9.6% | 0.09% | -5.1% |
| Q4 2019 | $7,391,000 | +21.7% | 1,250,475 | +11.2% | 0.10% | +11.4% |
| Q3 2019 | $6,075,000 | -33.1% | 1,125,000 | 0.0% | 0.09% | -24.8% |
| Q2 2019 | $9,079,000 | +1.9% | 1,125,000 | 0.0% | 0.12% | -0.8% |
| Q1 2019 | $8,910,000 | +103.9% | 1,125,000 | +12.5% | 0.12% | +84.4% |
| Q4 2018 | $4,370,000 | – | 1,000,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 300,000 | $2,421,000 | 1.60% |
| SV Health Investors, LLC | 285,765 | $2,306,000 | 1.55% |
| Alyeska Investment Group, L.P. | 1,125,000 | $9,079,000 | 0.12% |
| FEDERATED HERMES, INC. | 2,189,400 | $17,668,000 | 0.04% |
| OXFORD ASSET MANAGEMENT LLP | 139,451 | $1,125,000 | 0.02% |
| OPPENHEIMER & CO INC | 68,706 | $554,000 | 0.02% |
| Curi RMB Capital, LLC | 60,618 | $489,000 | 0.01% |
| Blackstone Inc. | 200,819 | $1,621,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 20,900 | $169,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 218,651 | $1,765,000 | 0.00% |